Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2024
2024-10-07 09:45
The exercise period for warrants of series TO7 in Prolight Diagnostics begins today
Regulatory
2024-10-03 18:45
The exercise price for the warrants of series TO7 in Prolight Diagnostics has been determined to SEK 0.12 per share
Regulatory
2024-09-30 15:40
Prolight Diagnostics publishes investor letter for september 2024
2024-09-26 08:30
Prolight showcases Psyros™ to global key opinion leaders in cardiology at 2024 Cardiac Markers Dialogue Meeting
Regulatory
2024-09-25 14:30
Prolight conducts business review at FlexMedical Solutions
2024-08-30 13:48
Emergers publishes an updated analysis on Prolight Diagnostics, reaffirming a justified value of 1.1-1.2 SEK per share
2024-08-28 08:00
Prolight Diagnostics publishes half-year report, 2024
Regulatory
MAR
2024-07-03 08:00
Prolight Diagnostics presents the Psyros system at ADLM, one of the world's largest and most important diagnostics congresses
Regulatory
2024-06-04 08:35
Warrants of series TO6 were exercised to approximately 44.8 percent and Prolight Diagnostics receives approximately SEK 9.8 million
Regulatory
MAR
2024-05-29 08:00
Prolight has obtained subscription commitments for exercising warrants of series TO6 from, among others, members of the Board and management of approximately SEK 1.0 million
Regulatory
Previous
Next